- Home
- Skills
- Trading & Investing
- shelved-asset-scout
Shelved Asset Scout
Surface de-prioritized pharmaceutical assets and "communication cliffs" for investment and licensing opportunities.
Free
Works with the AI Agents you already use
shelved-asset-scout
Example session with this skill installed
Analyze AstraZeneca's recent press releases to identify any high-confidence oncology assets that have experienced a communication cliff or strategic deprioritization since late 2024.
- Read your context and instructions
- Compiled the shelved-asset-scout
CONFIDENCE: HIGH | Asset: AZD-9291 | Company: AstraZeneca
Strategy: Communication Cliff, Asset Outside Strategy
Last Mention: 2024-08-15
Note: Selective silence detected. Total PR volume remains at 12/month, but asset mentions dropped to zero following the oncology portfolio restructuring.
Connects securely to your tools. The creator never sees your data.
About this skill
Pharma De-prioritization Intelligence
The shelved-asset-scout is a specialized pharmaceutical intelligence skill designed for investors, M&A analysts, and licensing professionals. In the fast-moving biotech landscape, pharmaceutical giants often quietly "shelf" promising assets due to strategic pivots, restructuring, or resource reallocation. This skill surfaces those hidden opportunities by analyzing years of corporate communications.
What it does
This tool utilizes a sophisticated multi-phase workflow to detect assets that have been deprioritized or discontinued. It connects to the PharmaceuticIndex MCP server to access a deep corpus of press releases and corporate data. It doesn't just look for explicit keywords like "discontinued"; it uses a Long-Arc Method to identify "communication cliffs"—where an asset mentioned regularly suddenly vanishes from the corporate narrative while overall company activity remains stable.
Key Features
- Signal Taxonomy: Categorizes opportunities into five distinct rungs, including EOL corporate-speak, strategy pivots, and out-licensing solicitations.
- Gap vs. Silence Discrimination: Employs logic to distinguish between actual asset deprioritization and systemic data ingestion artifacts.
- Semantic Confirmation: Leverages Voyage embeddings to confirm asset absence and detect if a company has pivoted focus to a different therapeutic area.
- Cadence Calibration: Automatically assesses if a company publishes frequently enough for "silence" to be a statistically significant investment signal.
Why use this skill?
Monitoring thousands of pipeline assets manually is impossible. Standard keyword searches often fail because companies use nuanced "corporate-speak" to bury bad news or strategic shifts. This skill automates the detection of multi-year silence arcs, providing a structured, confidence-weighted list of candidates ready for acquisition or licensing outreach.
- Requires active PharmaceuticIndex subscription
- Signal detection limited to 2020-present data
- Keyword search is term-specific (does not support complex boolean nesting)
How to use
- 1
Connect your agent to the Agensi MCP
Copy the prompt and paste it into Claude, ChatGPT, Cursor or any agent that supports MCP. It sets up the connection for you. Manual setup
- 2
Sign in to Agensi
Your agent shows a sign-in link. Sign in and click Allow.
- 3
Ask for what you need
Your agent loads this skill and uses it on your task. It always asks before any payment.
Reviews
This skill has been used 14 times.
Trust & safety
Security scan
Security scan passed 5 months ago
- Free with an Agensi account
Permissions
No special permissions declared or detected